| Literature DB >> 30377534 |
Paul D McGreevy1, Bethany J Wilson1, Caroline S Mansfield2, Dave C Brodbelt3, David B Church4, Navneet Dhand5, Ricardo J Soares Magalhães6,7, Dan G O'Neill3.
Abstract
BACKGROUND: Labrador retrievers are reportedly predisposed to many disorders but accurate prevalence information relating to the general population are lacking. This study aimed to describe demography, mortality and commonly recorded diseases in Labrador retrievers under UK veterinary care.Entities:
Keywords: Breed; Dog; Electronic patient record; Epidemiology; Pedigree; Primary-care; Purebred; VetCompass™
Year: 2018 PMID: 30377534 PMCID: PMC6196571 DOI: 10.1186/s40575-018-0064-x
Source DB: PubMed Journal: Canine Genet Epidemiol ISSN: 2052-6687
Fig. 1Annual proportional birth rates (2004–2013) for Labrador retrievers (n = 33,320) among all dogs (n = 455,557) attending UK primary-care veterinary clinics participating in the VetCompass™ Programme
Demography of Labrador retrievers under primary veterinary care at practices participating in the VetCompass™ Programme in the UK from January 1st 2013 to December 31st 2013 (n = 33,320)
| Variable | Category | Counta | Percent |
|---|---|---|---|
| Sex | Female | 15,427 | 46.4 |
| Male | 17,796 | 53.6 | |
| Female neuter | Entire | 5007 | 40.3 |
| Neutered | 7419 | 59.7 | |
| Male neuter | Entire | 6460 | 45.2 |
| Neutered | 7828 | 54.8 | |
| Age (years) | < 3.0 | 4892 | 32.1 |
| 3.0–5.9 | 4094 | 26.8 | |
| 6.0–8.9 | 3141 | 20.6 | |
| 9.0–11.9 | 2026 | 13.3 | |
| ≥ 12.0 | 1103 | 7.2 |
aCount covers dogs with available data
Fig. 2Bodyweight growth curves overlaid with a cross medians line plot for female and male Labrador retrievers attending UK primary-care veterinary clinics participating in the VetCompass™ Programme. (Females n = 10,228, Males n = 12,069)
Mortality in Labrador retrievers with a recorded cause of death under primary-care veterinary at UK practices participating in the VetCompass™ Programme from January 1st, 2013 to December 31st, 2013 (n = 147)
| Grouped-level disorder | Overall Count (%) | Female count (%) | Male Count (%) | Age at death [years]: Median (interquartile range) | |
|---|---|---|---|---|---|
| Musculoskeletal disorder | 36 (24.5) | 18 (24.3) | 18 (25.0) | 0.925 | 13.4 (11.5–14.0) |
| Neoplasia | 31 (21.1) | 13 (17.6) | 18 (25.0) | 0.272 | 10.6 (8.5–12.4) |
| Mass lesion | 11 (7.5) | 5 (6.8) | 6 (8.3) | 0.718 | 9.7 (9.0–10.1) |
| Brain disorder | 8 (5.4) | 5 (6.8) | 3 (4.2) | 0.492 | 11.8 (9.5–13.1) |
| Liver disorder | 8 (5.4) | 3 (4.1) | 5 (6.9) | 0.443 | 12.0 (9.3–12.9) |
| Renal disease | 8 (5.4) | 5 (6.8) | 3 (4.2) | 0.492 | 11.3 (8.7–13.3) |
| Endocrine disorder | 7 (4.8) | 5 (6.8) | 2 (2.8) | 0.261 | 12.1 (11.1–13.7) |
| Enteropathy | 5 (3.4) | 3 (4.1) | 2 (2.8) | 0.672 | 10.3 (5.4–11.0) |
| Heart disease | 5 (3.4) | 2 (2.7) | 3 (4.2) | 0.627 | 9.1 (8.2–12.1) |
| Urinary system disorder | 4 (2.7) | 1 (1.4) | 3 (4.2) | 0.297 | 12.7 (11.5–13.9) |
| Other | 24 (16.3) | ||||
| Total | 147 (100) |
The P-value reflects comparison between the prevalence in females and males
Prevalence of the most common disorders at a fine-level of diagnostic precision recorded in Labrador retrievers (n = 2074) attending UK primary-care veterinary practices participating in the VetCompass™ Programme from January 1st, 2013 to December 31st, 2013
| Fine-level disorder | Count | Overall prevalence % | 95% CI | Female prevalence % | Male prevalence % | |
|---|---|---|---|---|---|---|
| Otitis externa | 215 | 10.4 | 9.1–11.8 | 10.3 | 10.6 | 0.821 |
| Overweight/obesity | 183 | 8.8 | 7.6–10.1 | 9.8 | 8.0 | 0.139 |
| Degenerative joint disease | 115 | 5.5 | 4.6–6.6 | 5.9 | 5.2 | 0.480 |
| Lameness | 91 | 4.4 | 3.5–5.4 | 4.1 | 4.7 | 0.521 |
| Periodontal disease | 87 | 4.2 | 3.4–5.1 | 4.5 | 3.9 | 0.525 |
| Lipoma | 85 | 4.1 | 3.3–5.0 | 3.8 | 4.4 | 0.484 |
| Vomiting | 74 | 3.6 | 2.8–4.5 | 2.5 | 4.6 |
|
| Diarrhoea | 67 | 3.2 | 2.5–4.1 | 2.9 | 3.4 | 0.494 |
| Conjunctivitis | 57 | 2.7 | 2.1–3.5 | 3.0 | 2.6 | 0.577 |
| Skin mass | 51 | 2.5 | 1.8–3.2 | 2.4 | 2.6 | 0.756 |
| Pruritus | 43 | 2.1 | 1.5–2.8 | 2.2 | 2.0 | 0.832 |
| Anal sac impaction | 38 | 1.8 | 1.3–2.5 | 1.6 | 2.0 | 0.522 |
| Pyoderma | 36 | 1.7 | 1.2–2.4 | 1.5 | 1.9 | 0.499 |
| Coughing | 33 | 1.6 | 1.1–2.2 | 1.6 | 1.6 | 0.885 |
| Stiffness | 33 | 1.6 | 1.1–2.2 | 2.2 | 1.1 | 0.057 |
| Undesirable behaviour | 31 | 1.5 | 1.0–2.1 | 1.3 | 1.7 | 0.551 |
| Pyo-traumatic dermatitis | 28 | 1.4 | 0.9–1.9 | 1.1 | 1.6 | 0.396 |
| Alopecia | 26 | 1.3 | 0.8–1.8 | 1.0 | 1.5 | 0.367 |
| Pododermatitis | 26 | 1.3 | 0.8–1.8 | 1.0 | 1.5 | 0.367 |
| Laceration | 25 | 1.2 | 0.8–1.8 | 1.3 | 1.1 | 0.632 |
The P-value reflects prevalence comparison between females and males
P-values in bold are statistically significant
CI confidence interval
Colour variation among Labrador retrievers in their prevalence of the most common disorders at a fine-level of diagnostic precision recorded at UK primary-care veterinary practices participating in the VetCompass™ Programme from January 1st, 2013 to December 31st, 2013
| Fine-level disorder | Overall prevalence % | Black prevalence % | Chocolate prevalence % | Yellow prevalence % | |
|---|---|---|---|---|---|
| Otitis externa | 10.4 | 12.8 | 23.4 | 17.0 |
|
| Overweight/obesity | 8.8 | 13.0 | 15.4 | 16.7 | 0.272 |
| Degenerative joint disease | 5.5 | 10.7 | 6.7 | 8.8 | 0.152 |
| Lameness | 4.4 | 6.9 | 6.7 | 7.7 | 0.850 |
| Periodontal disease | 4.2 | 7.6 | 5.7 | 6.9 | 0.581 |
| Lipoma | 4.1 | 7.2 | 4.7 | 8.0 | 0.217 |
| Vomiting | 3.6 | 6.0 | 6.7 | 4.0 | 0.259 |
| Diarrhoea | 3.2 | 5.4 | 6.4 | 4.2 | 0.468 |
| Conjunctivitis | 2.7 | 4.3 | 5.0 | 4.5 | 0.900 |
| Skin mass | 2.5 | 3.8 | 4.7 | 3.5 | 0.701 |
| Pruritus | 2.1 | 2.9 | 4.7 | 3.2 | 0.371 |
| Anal sac impaction | 1.8 | 3.4 | 2.0 | 2.7 | 0.473 |
| Pyoderma | 1.7 | 2.9 | 4.0 | 2.1 | 0.349 |
| Coughing | 1.6 | 2.5 | 3.3 | 2.1 | 0.605 |
| Stiffness | 1.6 | 2.4 | 3.0 | 2.4 | 0.824 |
| Undesirable behaviour | 1.5 | 3.3 | 1.7 | 2.1 | 0.314 |
| Pyo-traumatic dermatitis | 1.4 | 1.1 | 4.0 | 1.6 |
|
| Alopecia | 1.3 | 2.0 | 3.0 | 1.3 | 0.303 |
| Pododermatitis | 1.3 | 1.4 | 3.0 | 1.9 | 0.284 |
| Laceration | 1.2 | 2.4 | 1.7 | 1.6 | 0.661 |
The P-value reflects prevalence comparison between the three colours. (n = 2074)
P-values in bold are statistically significant
Prevalence of the most common grouped-level disorders recorded in Labrador retrievers (n = 2074) attending UK primary-care veterinary practices participating in the VetCompass™ Programme from January 1st 2013 to December 31st 2013
| Grouped-level disorder | Count | Overall prevalence | 95% CI | Female prevalence % | Male prevalence % | |
|---|---|---|---|---|---|---|
| Musculoskeletal | 261 | 12.6 | 11.1–14.1 | 13.5 | 11.8 | 0.248 |
| Aural | 219 | 10.6 | 9.3–12.0 | 10.5 | 10.7 | 0.835 |
| Enteropathy | 210 | 10.1 | 8.9–11.5 | 8.7 | 11.3 | 0.052 |
| Dermatological | 202 | 9.7 | 8.5–11.1 | 9.6 | 9.9 | 0.832 |
| Overweight/obesity | 183 | 8.8 | 7.6–10.1 | 9.8 | 8.0 | 0.139 |
| Neoplasia | 153 | 7.4 | 6.3–8.6 | 7.4 | 7.4 | 0.963 |
| Dental | 114 | 5.5 | 4.6–6.6 | 5.7 | 5.3 | 0.679 |
| Mass-associated | 100 | 4.8 | 3.9–5.8 | 4.7 | 5.0 | 0.799 |
| Ophthalmological | 97 | 4.7 | 3.8–5.7 | 5.3 | 4.0 | 0.164 |
| Traumatic | 73 | 3.5 | 2.8–4.4 | 3.0 | 4.0 | 0.190 |
| Upper respiratory tract | 54 | 2.6 | 2.0–3.4 | 2.7 | 2.6 | 0.892 |
| Undesirable behaviour | 53 | 2.6 | 1.9–3.3 | 2.4 | 2.8 | 0.570 |
| Anal sac | 46 | 2.2 | 1.6–2.9 | 2.1 | 2.4 | 0.605 |
| Parasitic | 36 | 1.7 | 1.2–2.4 | 1.6 | 1.8 | 0.735 |
| Urinary system | 32 | 1.5 | 1.1–2.2 | 2.3 | 0.9 |
|
The P-value reflects prevalence comparison between females and males
P-values in bold are statistically significant
CI confidence interval